IIFL Capital Q1 FY27 Earnings Call — Analysis (NSE: IIFLCAPS)
Fairfax to invest INR2,000 Cr at ₹350/share for 51% stake pending regulatory approvals; Q1 revenue flat at INR631 Cr.
The take
Q1FY27 Consolidated Operational Revenue ₹631 Cr ( flat YoY ) . New story: Fairfax stake increase to 51% .
Results
Consolidated operational revenue ₹631 Cr flat YoY and QoQ; retail broking ₹297 Cr (+13% YoY), institutional & IB ₹207 Cr (flat), distribution ₹125 Cr (-14% YoY); operational PBT ₹149 Cr (-9% YoY).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Consolidated Operational Revenue | ₹631 Cr | +flat | yoy · Q1FY27 · flat YoY and QoQ |
| Retail Broking Revenue | ₹297 Cr | +13% | yoy · Q1FY27 |
| Institutional & IB Revenue | ₹207 Cr | +flat | yoy · Q1FY27 |
| Financial Product Distribution Income | ₹125 Cr | -14% | yoy · Q1FY27 |
| Employee Cost | ₹179 Cr | +flat | yoy · Q1FY27 |
| Finance Cost | ₹60 Cr | +50% | yoy · Q1FY27 |
| Operational PBT | ₹149 Cr | -9% | yoy · Q1FY27 |
| Other Income (MTM on BSE shares) | ₹90 Cr | +na | point_in_time · Q1FY27 · MTM gains on BSE shares |
| Net AUM Collections (FPD) | ₹3,675 Cr | +na | point_in_time · Q1FY27 · Net collections in Q1FY27 |
What management committed to
- From next quarter we'll start to catch up on [FPD AUM growth]. — Q2FY27
- We think that maybe in the next 2 to 3 months we'll get all the [regulatory] approvals and once the approvals come, only then the preferential allotment [of INR2,000 Cr to Fairfax] will take place. — Q3FY27
Key themes
Fairfax investment and regulatory approvals
How the narrative shifted
- Fairfax stake increase to 51%: Fairfax investment will strengthen capital base, support growth, and enhance brand credibility through global reach.
- Global macro uncertainty: Crude at $100 and geopolitical volatility may affect India, adding caution to outlook.
- SEBI margin norm impact: Marginal impact so far, but too early to judge; some impact may emerge over time.
- AUM growth one-off slowdown: Q1 net collections ₹3,675 Cr, a temporary blip, with recovery expected from next quarter.
- Asset management manufacturing push: Building in-house AIF, PMS, credit and late-stage funds while retaining open architecture.
Operational commentary
- Fairfax India Holdings proposed to increase stake to at least 51% via INR2,000 Cr preferential issue at ₹350/share and open offer; EGM approved; pending regulatory approvals from SEBI, NSE, BSE, IRDAI; expected closure in 2-3 months.
- SEBI margin norms implemented from 1 July; management sees marginal impact so far, full effect remains uncertain.
- Income tax demand of ₹124 Cr received post search; appeals filed.
- Asset management manufacturing push: AIF, PMS, credit fund, late-stage fund launched; AUM ~₹4,400 Cr; income reported under financial product distribution.
- RM additions minimal (single digit) in Q1.
Analyst Q&A
Q. Why did AUM growth slow this quarter?
Net collections were ₹3,675 Cr; maybe a one-off, and from next quarter we'll start to catch up.
Q. Have you received the Fairfax funds yet and how will they be deployed?
Not yet; subject to regulatory approvals expected in 2-3 months.
Q. Is there any impact from SEBI margin norms on the broking business?
Marginal impact so far, but too early to comment; may see some impact over time.
Q. Can you provide breakup of institutional broking vs investment banking revenue?
Roughly 50-50 or 60-40.
Research and educational content only. Not investment advice.